BP101

DRUG3 trials

Sponsors

Ivix LLX

Conditions

Female Sexual DysfunctionHypoactive Sexual Desire DisorderHypoactive Sexual Desire Disorder (HSDD)Hypoactive Sexual Desire Disorder(HSDD)Sexual Desire Disorder

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers

CompletedNCT03102489

Ivix LLXHypoactive Sexual Desire Disorder(HSDD)

Start: 2017-02-22End: 2017-09-19Updated: 2020-02-11

Phase 2

Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire

CompletedNCT03080298

Ivix LLXHypoactive Sexual Desire Disorder (HSDD)

Start: 2016-03-14End: 2017-07-25Updated: 2017-08-18

Phase 3

BP101 for Adults With Female Sexual Dysfunction

CompletedNCT03463707

Ivix LLXFemale Sexual Dysfunction, Hypoactive Sexual Desire Disorder, Sexual Desire Disorder

Start: 2018-03-05End: 2019-01-23Updated: 2020-02-11